Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Characteristics of the case-control studies included in the meta-analysisAuthorYearCity/CountryRegionGene (SNP)Grouping (M/F/Total)Mean Age ± Standard Deviation (years)Inclusion CriteriaExclusion CriteriaMossetti G2003Naples,ItalyEuropeVitamin D ReceptorCases (128/92/220)41.09 ± 14Recurrent stone forming patients with two or more calcium stones in the past 4 yearsUrinary tract infections (UTI), hyperparathyroidism, cystinuria, gouty diathesis, renal tubular acidosis, low creatinine clearance, chronic diarrhoeal states, intake of thiazide diuretics, angiotensin-converting enzyme (ACE)inhibitors, glucocorticoids or oestrogensControls (63/51/114)40.37 ± 14.07Unrelated healthy subjects without history of nephrolithiasispresence of one or more metabolic risk factor for nephrolithiasisRendina D2004Naples,ItalyVitamin D ReceptorCases (94/65/159)43.2 ± 10.9Unrelated patients with recurrent stone formation with 2 or more calcium stones within previous 4 years and idiopathic hypercalciuria.Gouty diathesis; cystinuria; renal tubular acidosis; low creatinine clearance; debilitating physical illnesses; hyperthyroidism; primary hyperparathyroidism, Paget’s bone disease, urinary infections, use of corticosteroid, diuretics, NSAID, vitamin D, or lithium.Controls (72/52/124)41.9 ± 10.4Unrelated healthy subjects without history of nephrolithiasis.presence of idiopathic hypercalciuria with a nonrestricted diet.Esposito T2017Naples,ItalyMelatonin Receptor 1 ACases (136/110/236)40.2 ± 12.0Idiopathic recurrent calcium stone former with at least 2 or more history of calcium oxalate stoneExclusion criteria is the same with (Mosseti G, 2003)Controls (141/128/269)40.3 ± 11.8Healthy without history of nephrolithiasisShakhssalim N2010Tehran/IranMiddle EastCalcium-Sensing ReceptorCases (99/-/99)43.4 ± 6.9Idiopathic recurrent calcium kidney stone-forming men with 2 symptomatic episodes at least 6 months apart during the past 5 yearshistory of metabolic, gastrointestinal, hepatic, renal, or endocrinological diseaseControl (99/-/107)38.4 ± 6.9Healthy volunteer men in the same age rangeAykan S2015Istanbul/TurkeyUrokinase & Vitamin D ReceptorCases (50/28/78)41Recurrent urolithiasisPatients taking vitamin D and/or calcium supplement.Controls (87/80/167)45Healthy subjects with normal urinalysis and absence of stone in ultrasound studyAnother exclusion criteria for control group were patients with family history of urolithiasis.Yamate T2000Osaka/JapanOsteopontinCases (32/8/40)50.4Recurrent calcium-containg calculi at least 2 or more episodesControls (20/16/36)54.3Normal subjects without past history of urolithiasisChen WC2001Taichung/TaiwanEastern AsiaCalcitonin ReceptorCases (72/30/102)44.6 ± 12.05Recurrent calcium oxalate stonehypercalcemia, hyperuricemia, and hyperuricosuria, and urinary tract infections.Controls (60/45/105)53 ± 10.08Healthy volunteers with no history of stone disease or renal calcificationUrinary microscopic hematuriaChen WC2001Taichung/TaiwanInterleukin-1RaCases (117/35/152)44.62 ± 12.05Recurrent calcium oxalate stoneUrinary tract infection during period of stone treatmentControls (-/-/105)> 40Healthy volunteers who had no history of familial stone disease or renal calcificationUrinary microscopic hematuriaTsai FJ2002Taichung/TaiwanUrokinaseCases (118/35/153)44.2 ± 12.0Recurrent calcium oxalate stone of at least 2 episodes regardless of family history of stone diseaseSymptoms of urinary tract infectionControls (65/40/105)54.7Healthy volunteers who had no history of familial stone disease or cancerUrinary microscopic hematuriaHuang SH2005Taichung,TaiwanTAP2-2Cases (158/50/208)43.8 ± 11.7Recurrent idiopathic calcium oxalate stone disease regardless of family historyPatients with hypercalcemia, hyperuricemia, hyperuricosuria, and symptoms of urinary tract infectionsControls (147/63/210)53.2 ± 9.9Healthy volunteer over the age of 40 who had no familial history of stone diseasePatients with microscopic hematuriaLai KC2009Taichung/TaiwanInterleukin-18Cases (182/90/272)43.8 ± 11.7Recurrent idiopathic calcium stone oxalate stone disease regardless of family historyHypercalcemia, hyperuricaemia, or hyperurocosuria, and urinary tract infectionControls (73/31/104)53.2 ± 9.9Age: and gender: matched healthy volunteers with no familial history of stone diseasePatients with microscopic hematuriaChou YH2011Kaohsiung/TaiwanORAI 1Cases (34/20/54)53.87 ± 9.83At least two symptomatic episodes at least 6 months apart or new stones after treatmentPatients with noncalcium renal stoneControls (289/211/500)49.5 ± 15.5Normal urinalysis, no history of familial stone disease, and no renal calcification history

Source: Literature search and characteristics of studies. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Systematic review.

Systematic review

Uses explicit methods to identify, assess and summarise research on a defined question.

Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Genes polymorphism as risk factor of recurrent urolithiasis: a systematic review and meta-analysis

Source: Article title.

Genes polymorphism as risk factor of recurrent urolithiasis: a systematic review and meta-analysis

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Genes polymorphism as risk factor of recurrent urolithiasis: a systematic review and meta-analysis

Systematic review · BMC Nephrology · 2023

Original publication title

Genes polymorphism as risk factor of recurrent urolithiasis: a systematic review and meta-analysis

Nur Rasyid; Soefiannagoya Soedarman

© The Author(s) 2023

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Gene polymorphisms have significant roles in the development of urolithiasis, especially in the Middle Eastern region.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Urolithiasis is one of the most prevalent diseases worldwide. Its prevalence is rising, both in developing and developed countries. It is known that genetic factors play big roles in the development of urolithiasis. One of the suspected factors is gene polymorphism. This study aims to find an accurate estimate of the association between genetic polymorphism and the risk of recurrent urolithiasis.

Source: Introduction

Abstract: What methods does the paper describe?

A systematic review and meta-analysis were performed on 12 studies from 3 databases that investigated gene polymorphism as an risk factor of urolithiasis. The review was done using Review Manager® version 5.3.

Source: Methods

Abstract: Results

Insignificant heterogenicity was found in this study. Populations from Asia and the Middle East are more likely to experience recurrent urolithiasis. Additionally, variation in the VDR and urokinase genes, particularly in the Asian population, increases the risk of developing recurrent urolithiasis.

Source: Results

Abstract: Conclusions

Gene polymorphisms have significant roles in the development of urolithiasis, especially in the Middle Eastern region.

Source: Conclusions
Authors’ abstract

Introduction

Urolithiasis is one of the most prevalent diseases worldwide. Its prevalence is rising, both in developing and developed countries. It is known that genetic factors play big roles in the development of urolithiasis. One of the suspected factors is gene polymorphism. This study aims to find an accurate estimate of the association between genetic polymorphism and the risk of recurrent urolithiasis.

Methods

A systematic review and meta-analysis were performed on 12 studies from 3 databases that investigated gene polymorphism as an risk factor of urolithiasis. The review was done using Review Manager® version 5.3.

Results

Insignificant heterogenicity was found in this study. Populations from Asia and the Middle East are more likely to experience recurrent urolithiasis. Additionally, variation in the VDR and urokinase genes, particularly in the Asian population, increases the risk of developing recurrent urolithiasis.

Conclusions

Gene polymorphisms have significant roles in the development of urolithiasis, especially in the Middle Eastern region.

Publication and source details

Original title: Genes polymorphism as risk factor of recurrent urolithiasis: a systematic review and meta-analysis

Nur Rasyid; Soefiannagoya Soedarman

BMC Nephrology · 2023

© The Author(s) 2023https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.PUTI Saintekes 2020PUTI Saintekes 2020

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T14:24:54.380424+00:00

DOI: 10.1186/s12882-023-03368-y · PMC10709856